Page last updated: 2024-09-04

docetaxel anhydrous and Eyelid Neoplasms

docetaxel anhydrous has been researched along with Eyelid Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allali, J; Loulergue, P; Mir, O; Viard, JP1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Eyelid Neoplasms

ArticleYear
Possible pharmacokinetic interaction involving ritonavir and docetaxel in a patient with Kaposi's sarcoma.
    AIDS (London, England), 2008, Jun-19, Volume: 22, Issue:10

    Topics: Adult; Antineoplastic Agents; Contraindications; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Docetaxel; Drug Interactions; Drug Therapy, Combination; Eyelid Neoplasms; HIV Infections; HIV Protease Inhibitors; Humans; Male; Neutropenia; Ritonavir; Sarcoma, Kaposi; Taxoids

2008